Spots Global Cancer Trial Database for metastatic prostate carcinoma in the soft tissue
Every month we try and update this database with for metastatic prostate carcinoma in the soft tissue cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| PROState Pathway Embedded Comparative Trial | NCT04400656 | Prostate Cancer Non-metastatic ... Metastatic Pros... Prostate Adenoc... Metastatic Pros... Prostate Cancer... | 18 Years - | Imperial College London | ||
| Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer | NCT02215161 | Castration Leve... Hormone-Resista... Metastatic Pros... Prostate Carcin... PSA Progression Stage IV Prosta... | Selinexor | 18 Years - | University of California, San Francisco | |
| Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer | NCT03709550 | Castration Leve... Castration-Resi... Metastatic Pros... Prostate Carcin... PSA Level Great... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Decitabine Enzalutamide | 18 Years - | Roswell Park Cancer Institute | |
| Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate Cancer | NCT04085991 | Prostate Cancer Prostate Adenoc... Prostatic Neopl... Metastatic Pros... Metastatic Pros... Metastatic Pros... | 131I-PSMA-1095 ... | 18 Years - | Sir Mortimer B. Davis - Jewish General Hospital | |
| Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer | NCT03709550 | Castration Leve... Castration-Resi... Metastatic Pros... Prostate Carcin... PSA Level Great... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Decitabine Enzalutamide | 18 Years - | Roswell Park Cancer Institute | |
| Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer | NCT03751436 | Castration Leve... Castration-Resi... Metastatic Pros... Metastatic Pros... Prostate Carcin... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Enzalutamide Venetoclax | 18 Years - | Roswell Park Cancer Institute | |
| Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer | NCT03709550 | Castration Leve... Castration-Resi... Metastatic Pros... Prostate Carcin... PSA Level Great... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Decitabine Enzalutamide | 18 Years - | Roswell Park Cancer Institute | |
| Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer | NCT03751436 | Castration Leve... Castration-Resi... Metastatic Pros... Metastatic Pros... Prostate Carcin... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Enzalutamide Venetoclax | 18 Years - | Roswell Park Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
